{
  "DOI": "10.1038/ejhg.2009.10",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2009.10",
  "alternative-id": [
    "BFejhg200910"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Gurwitz",
      "given": "David",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Rodríguez-Antona",
      "given": "Cristina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Payne",
      "given": "Katherine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Newman",
      "given": "William",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gisbert",
      "given": "Javier P",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Mesa",
      "given": "Emma Gutiérrez",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ibarreta",
      "given": "Dolores",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2009,
        2,
        18
      ]
    ],
    "date-time": "2009-02-18T19:48:09Z",
    "timestamp": 1234986489000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T16:57:15Z",
    "timestamp": 1684429035000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        12,
        20
      ]
    ],
    "date-time": "2023-12-20T17:12:14Z",
    "timestamp": 1703092334006
  },
  "is-referenced-by-count": 34,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "8",
  "issued": {
    "date-parts": [
      [
        2009,
        2,
        18
      ]
    ]
  },
  "journal-issue": {
    "issue": "8",
    "published-print": {
      "date-parts": [
        [
          2009,
          8
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2009,
            2,
            18
          ]
        ],
        "date-time": "2009-02-18T00:00:00Z",
        "timestamp": 1234915200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg200910.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg200910",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg200910.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "991-998",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2009,
        2,
        18
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2009,
        2,
        18
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2009,
        8
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.2165/00003088-200746030-00001",
      "author": "A Teml",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "Clin Pharmacokinet",
      "key": "BFejhg200910_CR1",
      "unstructured": "Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M : Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet 2007; 46: 187–208.",
      "volume": "46",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10637-005-4020-8",
      "author": "S Coulthard",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "journal-title": "Invest New Drugs",
      "key": "BFejhg200910_CR2",
      "unstructured": "Coulthard S, Hogarth L : The thiopurines: an update. Invest New Drugs 2005; 23: 523–532.",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S1542-3565(04)00344-1",
      "author": "MC Dubinsky",
      "doi-asserted-by": "publisher",
      "first-page": "731",
      "journal-title": "Clin Gastroenterol Hepatol",
      "key": "BFejhg200910_CR3",
      "unstructured": "Dubinsky MC : Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004; 2: 731–743.",
      "volume": "2",
      "year": "2004"
    },
    {
      "DOI": "10.1002/14651858.CD000478.pub2",
      "doi-asserted-by": "crossref",
      "key": "BFejhg200910_CR4",
      "unstructured": "Timmer A, McDonald JW, Macdonald JK : Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007: CD000478."
    },
    {
      "DOI": "10.1001/archneur.62.12.1843",
      "author": "L Massacesi",
      "doi-asserted-by": "publisher",
      "first-page": "1843",
      "journal-title": "Arch Neurol",
      "key": "BFejhg200910_CR5",
      "unstructured": "Massacesi L, Parigi A, Barilaro A et al: Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging. Arch Neurol 2005; 62: 1843–1847.",
      "volume": "62",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.jaad.2005.07.059",
      "author": "AA Patel",
      "doi-asserted-by": "publisher",
      "first-page": "369",
      "journal-title": "J Am Acad Dermatol",
      "key": "BFejhg200910_CR6",
      "unstructured": "Patel AA, Swerlick RA, McCall CO : Azathioprine in dermatology: the past, the present, and the future. J Am Acad Dermatol 2006; 55: 369–389.",
      "volume": "55",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.onc.1209372",
      "author": "L Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1629",
      "journal-title": "Oncogene",
      "key": "BFejhg200910_CR7",
      "unstructured": "Wang L, Weinshilboum R : Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions. Oncogene 2006; 25: 1629–1638.",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.1136/gut.34.8.1081",
      "author": "WR Connell",
      "doi-asserted-by": "publisher",
      "first-page": "1081",
      "journal-title": "Gut",
      "key": "BFejhg200910_CR8",
      "unstructured": "Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE : Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993; 34: 1081–1085.",
      "volume": "34",
      "year": "1993"
    },
    {
      "DOI": "10.1093/rheumatology/keg442",
      "author": "GP Clunie",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Rheumatology (Oxford)",
      "key": "BFejhg200910_CR9",
      "unstructured": "Clunie GP, Lennard L : Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine. Rheumatology (Oxford) 2004; 43: 13–18.",
      "volume": "43",
      "year": "2004"
    },
    {
      "DOI": "10.1002/ibd.20160",
      "author": "JP Gisbert",
      "doi-asserted-by": "publisher",
      "first-page": "1106",
      "journal-title": "Inflamm Bowel Dis",
      "key": "BFejhg200910_CR10",
      "unstructured": "Gisbert JP, Luna M, Gonzalez-Lama Y et al: Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients. Inflamm Bowel Dis 2007; 13: 1106–1114.",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1572-0241.2007.01515.x",
      "author": "OA Shaye",
      "doi-asserted-by": "publisher",
      "first-page": "2488",
      "journal-title": "Am J Gastroenterol",
      "key": "BFejhg200910_CR11",
      "unstructured": "Shaye OA, Yadegari M, Abreu MT et al: Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients. Am J Gastroenterol 2007; 102: 2488–2494.",
      "volume": "102",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.cgh.2005.10.019",
      "author": "Z Zelinkova",
      "doi-asserted-by": "publisher",
      "first-page": "44",
      "journal-title": "Clin Gastroenterol Hepatol",
      "key": "BFejhg200910_CR12",
      "unstructured": "Zelinkova Z, Derijks LJ, Stokkers PC et al: Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin Gastroenterol Hepatol 2006; 4: 44–49.",
      "volume": "4",
      "year": "2006"
    },
    {
      "author": "DE Baker",
      "first-page": "150",
      "journal-title": "Rev Gastroenterol Disord",
      "key": "BFejhg200910_CR13",
      "unstructured": "Baker DE : Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy. Rev Gastroenterol Disord 2003; 3: 150–157.",
      "volume": "3",
      "year": "2003"
    },
    {
      "DOI": "10.1111/j.1440-1746.2005.03832.x",
      "author": "RB Gearry",
      "doi-asserted-by": "publisher",
      "first-page": "1149",
      "journal-title": "J Gastroenterol Hepatol",
      "key": "BFejhg200910_CR14",
      "unstructured": "Gearry RB, Barclay ML : Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J Gastroenterol Hepatol 2005; 20: 1149–1157.",
      "volume": "20",
      "year": "2005"
    },
    {
      "DOI": "10.1177/0961203307085255",
      "author": "U Boonsrirat",
      "doi-asserted-by": "publisher",
      "first-page": "132",
      "journal-title": "Lupus",
      "key": "BFejhg200910_CR15",
      "unstructured": "Boonsrirat U, Angsuthum S, Vannaprasaht S et al: Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. Lupus 2008; 17: 132–134.",
      "volume": "17",
      "year": "2008"
    },
    {
      "author": "RM Weinshilboum",
      "first-page": "651",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg200910_CR16",
      "unstructured": "Weinshilboum RM, Sladek SL : Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651–662.",
      "volume": "32",
      "year": "1980"
    },
    {
      "DOI": "10.2174/138945006779025446",
      "author": "RM Engen",
      "doi-asserted-by": "publisher",
      "first-page": "1641",
      "journal-title": "Curr Drug Targets",
      "key": "BFejhg200910_CR17",
      "unstructured": "Engen RM, Marsh S, Van Booven DJ, McLeod HL : Ethnic differences in pharmacogenetically relevant genes. Curr Drug Targets 2006; 7: 1641–1648.",
      "volume": "7",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.clpt.6100135",
      "author": "TS Jones",
      "doi-asserted-by": "publisher",
      "first-page": "729",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg200910_CR18",
      "unstructured": "Jones TS, Yang W, Evans WE, Relling MV : Using HapMap tools in pharmacogenomic discovery: the thiopurine methyltransferase polymorphism. Clin Pharmacol Ther 2007; 81: 729–734.",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s00228-007-0426-x",
      "author": "SK Kham",
      "doi-asserted-by": "publisher",
      "first-page": "373",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "BFejhg200910_CR19",
      "unstructured": "Kham SK, Soh CK, Liu TC et al: Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol 2008; 64: 373–379.",
      "volume": "64",
      "year": "2008"
    },
    {
      "DOI": "10.2217/14622416.7.5.783",
      "author": "ME van den Akker-van Marle",
      "doi-asserted-by": "publisher",
      "first-page": "783",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg200910_CR20",
      "unstructured": "van den Akker-van Marle ME, Gurwitz D, Detmar SB et al: Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe. Pharmacogenomics 2006; 7: 783–792.",
      "volume": "7",
      "year": "2006"
    },
    {
      "DOI": "10.7326/0003-4819-111-8-641",
      "author": "DH Present",
      "doi-asserted-by": "publisher",
      "first-page": "641",
      "journal-title": "Ann Intern Med",
      "key": "BFejhg200910_CR21",
      "unstructured": "Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI : 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111: 641–649.",
      "volume": "111",
      "year": "1989"
    },
    {
      "DOI": "10.2165/00002018-200629050-00003",
      "author": "L Hazell",
      "doi-asserted-by": "publisher",
      "first-page": "385",
      "journal-title": "Drug Saf",
      "key": "BFejhg200910_CR22",
      "unstructured": "Hazell L, Shakir SA : Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385–396.",
      "volume": "29",
      "year": "2006"
    },
    {
      "DOI": "10.2217/14622416.9.1.1",
      "author": "K Payne",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg200910_CR23",
      "unstructured": "Payne K : Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key. Pharmacogenomics 2008; 9: 1–4.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10620-006-9119-z",
      "author": "JP Gisbert",
      "doi-asserted-by": "publisher",
      "first-page": "1262",
      "journal-title": "Dig Dis Sci",
      "key": "BFejhg200910_CR24",
      "unstructured": "Gisbert JP, Gomollon F, Cara C et al: Thiopurine methyltransferase activity in Spain: a study of 14 545 patients. Dig Dis Sci 2007; 52: 1262–1269.",
      "volume": "52",
      "year": "2007"
    },
    {
      "author": "JP Gisbert",
      "first-page": "399",
      "journal-title": "Hepatogastroenterology",
      "key": "BFejhg200910_CR25",
      "unstructured": "Gisbert JP, Luna M, Mate J, Gonzalez-Guijarro L, Cara C, Pajares JM : Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Hepatogastroenterology 2006; 53: 399–404.",
      "volume": "53",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s002280050457",
      "author": "T Kroplin",
      "doi-asserted-by": "publisher",
      "first-page": "265",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "BFejhg200910_CR26",
      "unstructured": "Kroplin T, Weyer N, Gutsche S, Iven H : Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 1998; 54: 265–271.",
      "volume": "54",
      "year": "1998"
    },
    {
      "DOI": "10.1258/0004563042466866",
      "author": "L Ford",
      "doi-asserted-by": "publisher",
      "first-page": "498",
      "journal-title": "Ann Clin Biochem",
      "key": "BFejhg200910_CR27",
      "unstructured": "Ford L, Prout C, Gaffney D, Berg J : Whose TPMT activity is it anyway? Ann Clin Biochem 2004; 41: 498–500.",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1093/qjmed/95.7.439",
      "author": "SA Holme",
      "doi-asserted-by": "publisher",
      "first-page": "439",
      "journal-title": "QJM",
      "key": "BFejhg200910_CR28",
      "unstructured": "Holme SA, Duley JA, Sanderson J et al: Erythrocyte thiopurine methyl transferase assessment prior to AZA use in the UK. QJM 2002; 95: 439–444.",
      "volume": "95",
      "year": "2002"
    },
    {
      "DOI": "10.1111/j.1365-2710.2007.00805.x",
      "author": "EA Fargher",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "J Clin Pharm Ther",
      "key": "BFejhg200910_CR29",
      "unstructured": "Fargher EA, Tricker K, Newman W et al: Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. J Clin Pharm Ther 2007; 32: 187–195.",
      "volume": "32",
      "year": "2007"
    },
    {
      "DOI": "10.1046/j.1365-2036.2002.01353.x",
      "author": "A Ansari",
      "doi-asserted-by": "publisher",
      "first-page": "1743",
      "journal-title": "Aliment Pharmacol Ther",
      "key": "BFejhg200910_CR30",
      "unstructured": "Ansari A, Hassan C, Duley J et al: Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment Pharmacol Ther 2002; 16: 1743–1750.",
      "volume": "16",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s00228-007-0310-8",
      "author": "E Oliveira",
      "doi-asserted-by": "publisher",
      "first-page": "703",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "BFejhg200910_CR31",
      "unstructured": "Oliveira E, Quental S, Alves S, Amorim A, Prata MJ : Do the distribution patterns of polymorphisms at the thiopurine S-methyltransferase locus in sub-Saharan populations need revision? Hints from Cabinda and Mozambique. Eur J Clin Pharmacol 2007; 63: 703–706.",
      "volume": "63",
      "year": "2007"
    },
    {
      "DOI": "10.2217/14622416.9.3.303",
      "author": "SC Cooper",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg200910_CR32",
      "unstructured": "Cooper SC, Ford LT, Berg JD, Lewis MJ : Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population study. Pharmacogenomics 2008; 9: 303–309.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1002/ibd.20004",
      "author": "G Stocco",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "Inflamm Bowel Dis",
      "key": "BFejhg200910_CR33",
      "unstructured": "Stocco G, Martelossi S, Barabino A et al: Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 57–64.",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1365-2036.2008.03788.x",
      "author": "A Ansari",
      "doi-asserted-by": "publisher",
      "first-page": "973",
      "journal-title": "Aliment Pharmacol Ther",
      "key": "BFejhg200910_CR34",
      "unstructured": "Ansari A, Arenas M, Greenfield S et al: Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2008; 28: 973–983.",
      "volume": "28",
      "year": "2008"
    },
    {
      "DOI": "10.1038/clpt.2008.154",
      "author": "G Stocco",
      "doi-asserted-by": "publisher",
      "first-page": "164",
      "journal-title": "Clin Pharmacol Ther",
      "key": "BFejhg200910_CR35",
      "unstructured": "Stocco G, Cheok M, Crews K et al: Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther 2009; 85: 164–172.",
      "volume": "85",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.bcp.2008.07.026",
      "author": "LA Hogarth",
      "doi-asserted-by": "publisher",
      "first-page": "1024",
      "journal-title": "Biochem Pharmacol",
      "key": "BFejhg200910_CR36",
      "unstructured": "Hogarth LA, Redfern CP, Teodoridis JM et al: The effect of thiopurine drugs on DNA methylation in relation to TPMT expression. Biochem Pharmacol 2008; 76: 1024–1035.",
      "volume": "76",
      "year": "2008"
    },
    {
      "DOI": "10.1093/rheumatology/kel427",
      "author": "K Payne",
      "doi-asserted-by": "publisher",
      "first-page": "727",
      "journal-title": "Rheumatology (Oxford)",
      "key": "BFejhg200910_CR37",
      "unstructured": "Payne K, Newman W, Fargher E et al: TPMT testing in rheumatology: any better than routine monitoring? Rheumatology (Oxford) 2007; 46: 727–729.",
      "volume": "46",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.tpj.6500417",
      "author": "M Wadelius",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "journal-title": "Pharmacogenomics J",
      "key": "BFejhg200910_CR38",
      "unstructured": "Wadelius M, Pirmohamed M : Pharmacogenetics of warfarin: current status and future challenges. Pharmacogenomics J 2007; 7: 99–111.",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.2217/17410541.6.1.103",
      "author": "K Payne",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "journal-title": "Personalized Med",
      "key": "BFejhg200910_CR39",
      "unstructured": "Payne K, Newman WG, Gurwitz D, Ibarreta D, Phillips KA : TPMT testing in azathioprine: a ‘cost-effective use of healthcare resources’?. Personalized Med 2009; 6: 103–113.",
      "volume": "6",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.amjmed.2007.02.006",
      "author": "MJ McLaughlin",
      "doi-asserted-by": "publisher",
      "first-page": "S32",
      "issue": "4 Suppl 1",
      "journal-title": "Am J Med",
      "key": "BFejhg200910_CR40",
      "unstructured": "McLaughlin MJ : HTE Policy Roundtable Panel. Healthcare policy implications of heterogeneity of treatment effects. Am J Med 2007; 120 (4 Suppl 1): S32–S35.",
      "volume": "120",
      "year": "2007"
    },
    {
      "key": "BFejhg200910_CR41",
      "unstructured": "Department of Health and Human (HHS) Services Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS): Report: realizing the potential of pharmacogenomics: opportunities and challenges (May 2008). \n                    http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_PGx_report.pdf\n                    \n                  ."
    }
  ],
  "reference-count": 41,
  "references-count": 41,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg200910"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain"
  ],
  "type": "journal-article",
  "volume": "17"
}